News | August 28, 2023
Gland Pharma receives 2 observations under 483 for Pashamylaram facility
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
The company has entered into a three-year Deferred Prosecution Agreement
Eris Lifesciences enters into term loan agreement with Citi Bank
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Subscribe To Our Newsletter & Stay Updated
